Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sacha Uljon

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Research and Practice in Thrombosis and Haemostasis|February 27, 2026
The Thromboembolism Heparinization and AntithrombiN Observational Study (THANOS-1)Christiana K Prucnal, Grace Wang, Weixing Huang, et al.
The Journal of Experimental Medicine|March 10, 2020
Trib1 regulates T cell differentiation during chronic infection by restraining the effector programKelly S Rome, Sarah J Stein, Makoto Kurachi, et al.
Thrombosis and Haemostasis|June 25, 2026
Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study DesignBassil Bacare, Syed Bukhari, Nathan Watson, et al.
Nature Reviews. Cardiology|March 11, 2026
Antiphospholipid antibodies and cardiovascular thrombosisSina Rashedi, Hannah Leyva, Saman A Siddiqui, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Research and Practice in Thrombosis and Haemostasis|February 27, 2026
The Thromboembolism Heparinization and AntithrombiN Observational Study (THANOS-1)Christiana K Prucnal, Grace Wang, Weixing Huang, et al.
The Journal of Experimental Medicine|March 10, 2020
Trib1 regulates T cell differentiation during chronic infection by restraining the effector programKelly S Rome, Sarah J Stein, Makoto Kurachi, et al.
Thrombosis and Haemostasis|June 25, 2026
Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study DesignBassil Bacare, Syed Bukhari, Nathan Watson, et al.
Nature Reviews. Cardiology|March 11, 2026
Antiphospholipid antibodies and cardiovascular thrombosisSina Rashedi, Hannah Leyva, Saman A Siddiqui, et al.
Pageof 2